DBCO-β-Glu-PEG12-Exatecan is a drug-linker conjugate featuring the topoisomerase I inhibitor Exatecan. It is designed for constructing antibody-drug conjugates (ADCs) and is suitable for both in vitro biochemical assays and in vivo efficacy studies in cancer research.